HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Buchfelder Selected Research

Insulin-Like Growth Factor I (IGF-1)

12/2017Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly.
1/2016Neurosurgical Treatment of Acromegaly.
2/2013Control of disease activity and tumor size after introduction of pegvisomant in a lanreotide-resistant acromegalic patient.
8/2010Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Buchfelder Research Topics

Disease

88Neoplasms (Cancer)
05/2024 - 01/2000
31Glioma (Gliomas)
02/2022 - 03/2004
24Pituitary Neoplasms (Pituitary Adenoma)
05/2024 - 01/2003
19Adenoma (Adenomas)
12/2023 - 01/2000
16Glioblastoma (Glioblastoma Multiforme)
12/2022 - 05/2003
15Brain Neoplasms (Brain Tumor)
12/2022 - 02/2003
15Pituitary ACTH Hypersecretion
01/2022 - 01/2006
14Craniopharyngioma (Craniopharyngiomas)
10/2021 - 07/2005
13Acromegaly
05/2022 - 01/2007
12Epilepsy (Aura)
02/2023 - 02/2003
9Hypoxia (Hypoxemia)
05/2022 - 10/2018
8Meningioma (Meningiomas)
12/2022 - 07/2005
6Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
03/2024 - 01/2012
5Chronic Pain
10/2023 - 09/2019
5Prolactinoma (Prolactinomas)
12/2022 - 01/2000
5Brain Injuries (Brain Injury)
08/2022 - 09/2009
5Necrosis
10/2021 - 10/2018
5Edema (Dropsy)
10/2021 - 06/2008
5Traumatic Brain Injuries (Traumatic Brain Injury)
01/2020 - 09/2009
5Hydrocephalus (Hydrocephaly)
12/2018 - 01/2012
4Pain (Aches)
10/2023 - 08/2019
4Residual Neoplasm
04/2017 - 08/2007
4Brain Edema (Cerebral Edema)
06/2016 - 06/2008
4Cushing Syndrome
03/2015 - 04/2006
4Hippocampal Sclerosis
07/2014 - 05/2008
3Neuroinflammatory Diseases
01/2023 - 09/2019
3Inflammation (Inflammations)
01/2023 - 01/2007
3Neoplasm Metastasis (Metastasis)
12/2022 - 01/2009
3Body Weight (Weight, Body)
12/2022 - 05/2013
3Drug Resistant Epilepsy
11/2021 - 02/2012
3Obesity
10/2021 - 05/2013
3Carcinogenesis
12/2020 - 07/2005
3Hemorrhage
08/2019 - 08/2008
3Trigeminal Neuralgia (Tic Douloureux)
08/2019 - 10/2008
3Headache (Headaches)
01/2019 - 07/2010
3ACTH-Secreting Pituitary Adenoma
01/2019 - 03/2015
3Intracranial Aneurysm (Cerebral Aneurysm)
11/2017 - 02/2014
3Hypophysitis
11/2017 - 07/2006
3Central Nervous System Cysts (Suprasellar Cyst)
01/2016 - 12/2006
2Brain Ischemia (Cerebral Ischemia)
03/2024 - 10/2017
2Partial Epilepsies (Epilepsy, Partial)
02/2023 - 09/2007

Drug/Important Bio-Agent (IBA)

19Biomarkers (Surrogate Marker)IBA
01/2023 - 03/2013
15Oxygen (Dioxygen)IBA
12/2022 - 01/2017
13Adrenocorticotropic Hormone (ACTH)FDA Link
01/2022 - 04/2006
9Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2000
9pegvisomantFDA LinkGeneric
12/2018 - 01/2007
7Hormones (Hormone)IBA
12/2021 - 01/2003
6Glutamic Acid (Glutamate)FDA Link
10/2022 - 09/2014
6Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
05/2022 - 04/2008
6ProlactinIBA
12/2021 - 01/2000
6Temozolomide (Temodar)FDA LinkGeneric
01/2020 - 12/2014
6ErbB Receptors (EGF Receptor)IBA
01/2019 - 05/2003
6Growth Hormone (Somatotropin)IBA
01/2016 - 04/2008
5Dopamine Agonists (Dopamine Agonist)IBA
12/2022 - 01/2000
5Hydrocortisone (Cortisol)FDA LinkGeneric
01/2022 - 04/2006
5Messenger RNA (mRNA)IBA
08/2017 - 03/2004
5beta CateninIBA
05/2010 - 07/2005
4Neuroprotective AgentsIBA
03/2024 - 05/2006
4AntibodiesIBA
12/2022 - 01/2003
4GlucocorticoidsIBA
01/2022 - 07/2006
4Transcription Factors (Transcription Factor)IBA
12/2021 - 11/2018
4Sulfasalazine (Azulfidine)FDA LinkGeneric
10/2021 - 01/2015
4EnzymesIBA
05/2021 - 07/2010
4Ubiquitin-Specific ProteasesIBA
01/2019 - 07/2015
4Octreotide (Sandostatin)FDA LinkGeneric
12/2017 - 04/2006
4Insulin-Like Growth Factor I (IGF-1)IBA
12/2017 - 08/2010
4Small Interfering RNA (siRNA)IBA
11/2016 - 06/2008
4CateninsIBA
01/2015 - 10/2010
3LeptinIBA
01/2023 - 09/2019
3Glucose (Dextrose)FDA LinkGeneric
12/2022 - 07/2010
3Nerve Growth Factors (Neurotrophins)IBA
08/2022 - 07/2013
3Somatostatin Receptors (Somatostatin Receptor)IBA
05/2022 - 01/2010
3Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2022 - 10/2014
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 01/2014
3Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
04/2021 - 01/2017
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020 - 05/2003
3CytokinesIBA
09/2019 - 05/2003
3Amino Acid Transport System X-AG (Glutamate Transporter)IBA
06/2016 - 06/2008
3Peptides (Polypeptides)IBA
02/2016 - 07/2005
3Choline (Choline Chloride)IBA
08/2012 - 04/2007
3N-acetylaspartate (N-acetyl aspartate)IBA
08/2012 - 04/2007
3Protons (Proton)IBA
08/2008 - 04/2007
2Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric
03/2024 - 10/2017
2AdipokinesIBA
01/2023 - 12/2020

Therapy/Procedure

52Therapeutics
05/2024 - 05/2004
21Radiotherapy
05/2024 - 01/2009
7Drug Therapy (Chemotherapy)
01/2023 - 01/2009
5Operative Surgical Procedures
05/2024 - 11/2002
4Aftercare (After-Treatment)
01/2021 - 09/2010
4Craniotomy
06/2019 - 01/2008
4Ventriculoperitoneal Shunt
12/2018 - 01/2012
4Decompression
01/2016 - 10/2005
3Deep Brain Stimulation
03/2023 - 01/2022
3Injections
01/2022 - 01/2000
3Adrenalectomy
01/2022 - 01/2018
3Endoscopes
06/2019 - 01/2016
3Electrodes (Electrode)
01/2019 - 10/2016
3Combined Modality Therapy
12/2017 - 08/2014
3Lasers (Laser)
11/2017 - 07/2009
2Contraindications
12/2023 - 08/2007